Alven

Activity from announced rounds

Activity in this selectionUnited States · Oct 9, 2026 · Jan 1, 2026

Alven is an investment firm whose own news covers Archy’s Series C and which Attention identifies as a returning investor.

Recorded funding activity

Archy combines dental-practice operations and clinical software with AI tools for routine administrative work. Attention develops agents for revenue-team workflows. The recorded history also includes Generare, which produces molecular data for drug development. These company-level events connect Alven’s attribution across distinct business applications.

Sources
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$80M
2 disclosed · full round size, not this investor’s share

By stage

Series B1
Series C+1

By primary sector

AI1
Healthtech1

By country

United States2

Rounds

2 in this selection
Archy

Cloud software combines dental practice operations and clinical tools with AI agents for routine administrative work.

$50MSeries C
Participant
Attention

AI platform automates revenue team workflows with action-based AI agents

$30MSeries B
Role not disclosed